Long term mortality of patients with Parkinson's disease treated with deep brain stimulation in a reference center - ScienceDirect

Deep brain stimulation of the subthalamic nucleus in Parkinson's disease after 15 years: Clinical outcome and caregiver burden - ScienceDirect

Parkinson's disease: prospects for improved drug therapy: Trends in Pharmacological Sciences

Integrated and patient-centred management of Parkinson's disease: a network model for reshaping chronic neurological care - The Lancet Neurology

A detailed review of pathophysiology, epidemiology, cellular and molecular pathways involved in the development and prognosis of Parkinson's disease with insights into screening models, Bulletin of the National Research Centre

Comparative efficacy of surgical approaches to disease modification in Parkinson disease

Trends and disparities in deep brain stimulation utilization in the United States: a Nationwide Inpatient Sample analysis from 1993 to 2017 - The Lancet Regional Health – Americas

Deep brain stimulation of the subthalamic nucleus in Parkinson's disease after 15 years: Clinical outcome and caregiver burden - Deep Brain Stimulation

Treating addiction with deep brain stimulation: Ethical and legal considerations - ScienceDirect

Preclinical quality, safety, and efficacy of a human embryonic stem cell-derived product for the treatment of Parkinson's disease, STEM-PD - ScienceDirect

Pimavanserin for patients with Parkinson's disease psychosis: a randomised, placebo-controlled phase 3 trial - The Lancet

Cognition and Psychiatric Disturbances - 2023 - Movement Disorders - Wiley Online Library